On Friday, Ovid Therapeutics Inc (NASDAQ: OVID) was 22.70% up from the session before settling in for the closing price of $1.41. A 52-week range for OVID has been $0.24 – $1.47.
Annual sales at Healthcare sector company grew by 24.72% over the past five years. When this article was written, the company’s average yearly earnings per share was at -35.91%. With a float of $59.52 million, this company’s outstanding shares have now reached $71.11 million.
Ovid Therapeutics Inc (OVID) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Ovid Therapeutics Inc stocks. The insider ownership of Ovid Therapeutics Inc is 16.33%, while institutional ownership is 34.63%. The most recent insider transaction that took place on Feb 26 ’25, was worth 2,956. In this transaction President and COO of this company sold 5,279 shares at a rate of $0.56, taking the stock ownership to the 73,406 shares. Before that another transaction happened on Feb 26 ’25, when Company’s CBFO sold 3,902 for $0.56, making the entire transaction worth $2,185. This insider now owns 67,973 shares in total.
Ovid Therapeutics Inc (OVID) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.2 earnings per share (EPS) during the time that was better than consensus figure (set at -0.23) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year. According to the Wall Street analysts, stocks earnings will be around -35.91% per share during the next fiscal year.
Ovid Therapeutics Inc (NASDAQ: OVID) Trading Performance Indicators
You can see what Ovid Therapeutics Inc (OVID) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.72. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.54, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Ovid Therapeutics Inc (OVID)
Ovid Therapeutics Inc (NASDAQ: OVID) saw its 5-day average volume 2.9 million, a positive change from its year-to-date volume of 1.09 million. As of the previous 9 days, the stock’s Stochastic %D was 86.65%.
During the past 100 days, Ovid Therapeutics Inc’s (OVID) raw stochastic average was set at 94.19%, which indicates a significant increase from 87.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1317 in the past 14 days, which was higher than the 0.0682 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9617, while its 200-day Moving Average is $0.6237. Nevertheless, the first resistance level for the watch stands at $1.8933 in the near term. At $2.0567, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.2933. If the price goes on to break the first support level at $1.4933, it is likely to go to the next support level at $1.2567. The third support level lies at $1.0933 if the price breaches the second support level.
Ovid Therapeutics Inc (NASDAQ: OVID) Key Stats
There are 71,110K outstanding shares of the company, which has a market capitalization of 123.02 million. As of now, sales total 570 K while income totals -26,430 K. Its latest quarter income was 6,270 K while its last quarter net income were -4,680 K.
